INOXXOLT
Live / Applied — Second extension granted (statement of use) (as of 25 Nov 2025)
What this means for you
Not registered yet, but its 15 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98648880
- Mark type
- Stylized text
- Filed
- 15 Jul 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Andrea Christensen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 26 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Nov 2025 — SOU EXTENSION 2 GRANTED
- 25 Nov 2025 — SOU EXTENSION 2 FILED
- 25 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Nov 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 13 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jun 2025 — SOU EXTENSION 1 GRANTED
- 06 Jun 2025 — SOU EXTENSION 1 FILED
- 06 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION